Zentalis Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Zentalis Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q2 2024.
  • Zentalis Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 71.1M shares, a 0.71% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 71.1M +503K +0.71% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 71M +11.6M +19.5% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 70.8M +11.5M +19.4% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 70.6M +13.6M +23.9% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 70.6M +13.6M +23.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 59.4M +13.9M +30.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 59.3M +13.8M +30.3% Dec 31, 2022 10-K 2024-02-27
Q3 2022 57M +11.8M +26.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 57M +15.7M +37.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 45.6M +4.54M +11.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 45.5M +4.45M +10.8% Dec 31, 2021 10-K 2023-03-01
Q3 2021 45.2M +4.58M +11.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 41.3M +5.44M +15.2% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 41M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 41M Dec 31, 2020 10-K 2022-02-24
Q3 2020 40.6M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 35.9M Jun 30, 2020 10-Q 2020-08-13
Q4 2017 5.19M Dec 31, 2017 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.